Shares of Moderna (NASDAQ: MRNA) climbed 4.5% on Monday. The drugmaker is increasing its manufacturing capabilities at one of its U.S. plants to meet the rising demand for its COVID-19 vaccine, according to The Wall Street Journal

Moderna is adding two new production lines at its facility near Boston. One line could be ready as soon as this fall. The other is expected to be brought online early next year. Together, they're expected to boost the plant's production capacity by as much as 50%.

Image source: Getty Images.

Continue reading


Source Fool.com